Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.